pharma news today glp-1 obesity drug updates What is the pipeline for future medications for obesity? Lilly orforglipron oral GLP-1 phase

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans

Pediatric considerations Eczema is extremely common in children, affecting up to 20% of children in some countries

A typical clinical dose is 2 g of myo-inositol twice daily, often combined with D-chiro-inositol in a 40:1 ratio to mimic the physiological inositol balance found in healthy ovaries essentially topping up the ratio your ovaries would ideally maintain on their own

Important instructions: Do not exceed the recommended daily dose

doi: 10.3390/nu7064139 26 ArslanSAkdeveliogluY

This paper describes methimazole embryopathy, a rare but unpleasant complication of the drug